IEPFA and SEBI to Organize 'Niveshak Shivir' in New Delhi (See 'Corp Brief') Ministry of Power Pavilion showcases Power Sector Initiatives at IIFT (See 'Corp Brief') MY Bharat mobilises over 81,600 youth and citizens through Sports Meets (See 'Corp Brief') 12th Session of India-Belarus Inter-Governmental Commission held in New Delhi (See 'Corp Brief') CPC/Limitation - Entries in books of account & balance sheets can constitute acknowledgment of liability u/s 18 of Limitation Act, provided they indicate subsisting jural relationship when read with surrounding circumstances: SC LB (See 'Legal Desk') India to host Ministerial Meeting of International Coconut Community in Kochi (See 'Corp Brief') India Post releases Commemorative Postage Stamp on Pioneer of Biogas Technology (See 'Corp Brief') NICDC Pavilion showcases AP's Greenfield Industrial Smart Cities (See 'Corp Brief') CCPA imposes Penalty of Rs 20 Lakh on ExportersIndia.com (See 'Corp Brief') IBC - RP required to function independently & cannot act according to whims & fancies of a dominant Financial Creditor - CoC's majority decision to replace RP cannot be interfered with by another Financial Creditor holding minority voting share: NCLAT (See 'Legal Desk') IITF 2026 - EPFO Lounge & ESIC Pavilion inaugurated (See 'Corp Brief') Giriraj Singh visits Welspun World's State-of-the-Art Manufacturing Units in Kutch (See 'Corp Brief') PMLA - Status of secured creditor & initiation of prior recovery proceedings under SARFAESI Act do not exempt a property from attachment under PMLA, when property constitutes proceeds of crime: SAFEMA Tribunal (See 'Legal Desk') Indian Business leaders and Start ups to participate in the India-Egypt Business Forum (See 'Corp Brief') NRIDA selected for Medal for Innovation in Road Technology (See 'Corp Brief') PMLA - Objectives of special anti-money laundering law supersede private commercial security interests - properties linked to criminal activities liable to provisional & final attachment: SAFEMA Tribunal (See 'Legal Desk') Shilp Samagam Mela 2026 at Dilli Haat records Cumulative Sales of Over Rs 88.36 Lakh (See 'Corp Brief') National Tribal Literary Festival concludes with Emphasis on Preserving Oral Traditions (See 'Corp Brief') SEBI - Freezing the Appellants' demat & bank accounts pending deposit of alleged unlawful gains of Rs. 28.12 crore, is valid: SAT (See 'Legal Desk') An unsuccessful 'success fee' litigation (See CORP EINSICHT)

Glenmark's Swiss arm gets nod to market Ryaltris nasal spray in Russia

Published: Feb 22, 2021

By TIOLCORPLAWS News Service

NEW DELHI, FEB 22, 2021: GLENMARK Pharmaceuticals on Monday said its Swiss subsidiary, Glenmark Specialty, has received marketing approval from Russian health regulators for its fixed-dose combination nasal spray, Ryaltris.

Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, like stuffy and runny nose, nasal itching, sneezing, as well as irritated eyes, in adults and children over 12 years of age.

"Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally. Russia is one of the key markets for us and we are consistently looking to expand our product portfolio," said Csaba Kantor, Senior Vice President - Russia and CIS region, Glenmark.

In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent.

"Glenmark has a strong established presence in Russia for over 30 years, which will enable us to lead the commercialization of this product in the country. We look forward to being able to make this innovative product available to patients in Russia as soon as possible," Mr Kantor added.

The company estimated that Ryaltris will be available to patients in Russia by the first quarter of 2021-22.

TIOL CORP SEARCH

TIOL GROUP WEBSITES